SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-056209
Filing Date
2024-03-01
Accepted
2024-03-01 17:26:00
Documents
24
Period of Report
2024-02-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d759306d8k.htm   iXBRL 8-K 34903
2 EX-1.1 d759306dex11.htm EX-1.1 307803
3 EX-4.1 d759306dex41.htm EX-4.1 68101
4 EX-5.1 d759306dex51.htm EX-5.1 13085
5 EX-99.1 d759306dex991.htm EX-99.1 9722
6 EX-99.2 d759306dex992.htm EX-99.2 10242
10 GRAPHIC g759306g0301143011164.jpg GRAPHIC 3915
11 GRAPHIC g759306g0301143025981.jpg GRAPHIC 3902
12 GRAPHIC g759306g0301145037410.jpg GRAPHIC 6154
13 GRAPHIC g759306g11y65.jpg GRAPHIC 4671
14 GRAPHIC g759306g36u78.jpg GRAPHIC 3847
  Complete submission text file 0001193125-24-056209.txt   720238

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA tars-20240229.xsd EX-101.SCH 2840
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE tars-20240229_lab.xml EX-101.LAB 18736
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tars-20240229_pre.xml EX-101.PRE 11700
25 EXTRACTED XBRL INSTANCE DOCUMENT d759306d8k_htm.xml XML 3776
Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Filer) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39614 | Film No.: 24711723
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)